Alzheimer’s disease drugs offer hope, but humane dementia care preserves humanity in advanced dementia

Author and source

Kate Irving, writing for The Conversation, discusses how disease-modifying drugs for Alzheimer’s offer a hopeful glimpse of progress while underscoring the ongoing need for compassionate dementia care that preserves humanity for those who cannot benefit from these drugs.

Key insights

• Drugs may slow progression by months and carry risks such as brain swelling or bleeding, and are currently suitable only for some people in the early stages.
• Dementia care must address the whole person, not just biology, using music, poetry, storytelling, theatre, visual art, and museum work to foster recognition and connection.
• Public conversation risks narrowing to biology and can marginalize those with advanced dementia who may not express themselves in familiar ways.
• Narrative dispossession and critical fabulation offer ethical frameworks to engage with inner lives while acknowledging limits of interpretation.

Author: Kate Irving, The Conversation

Alzheimer’s disease and the promise and limits of disease modifying therapies

The article opens by explaining that disease modifying treatments for Alzheimer’s disease are designed to slow the disease process itself, rather than merely relieve symptoms. Early data suggest these drugs may delay the progression of clinically observable symptoms by months rather than years, and they come with notable risks including swelling and bleeding in the brain. The therapies are currently suitable only for some individuals in the very early stages of Alzheimer’s disease, meaning many people with dementia will still face the condition with no definitive cure on the horizon.

Beyond the clinical facts, the piece emphasizes that this scientific progress has sparked broad interest and investment in dementia research. Yet public excitement can be misdirected if it concentrates primarily on biology at the expense of people living with dementia and their daily experiences. The author argues that dementia begins in the brain but affects the whole person, influencing memory, communication, relationships, and how individuals make sense of the world.

Dementia care as human-centered practice

The article makes a powerful case that care for people with dementia must do more than slow biological decline. It should help individuals feel recognized, connected, and still themselves. Creative and relational activities can provide meaningful ways for people to respond and connect when ordinary conversation becomes difficult. Music, poetry, storytelling, theatre, visual art, dance, and museum-based activities are highlighted as ways to reduce distress, support identity, and create moments of meaning, even if they do not fit neatly within traditional evidence frameworks used to evaluate drugs.

As these interventions become more commonplace and extend into later stages of the disease, they reveal the humanity of people living with dementia for longer. This visibility challenges harmful stereotypes that frame dementia as a living death or portray individuals as zombies or empty shells. The piece cautions that focusing only on those who can communicate in conventional ways risks leaving those with advanced dementia behind, inaccessible to research and creative engagement.

Ethical engagement with late-stage dementia

The article introduces two concepts from social science that can guide ethical practice in the late stages of dementia: narrative dispossession and critical fabulation. Narrative dispossession refers to the loss of control over one’s story as dementia progresses, raising questions about how carers and researchers should respond to fragments of memory that remain. Critical fabulation describes a careful form of imaginative reconstruction used when direct evidence is partial, allowing for plausible inferences about inner experiences while staying honest about interpretive limits. When applied to dementia care, these ideas encourage humility and relational care, ensuring that the care team does not replace a person’s voice with their own assumptions.

The author stresses that choosing not to engage imaginatively with a person’s inner life can erase those in the latest stages of dementia. Ethical care, therefore, must balance imaginative engagement with restraint and a firm commitment to relational ethics. This approach helps ensure that even those who cannot tell their stories in familiar ways remain seen and valued.

Implications for policy, research, and practice

New drugs may help some people remain in earlier stages for longer, but they will do little or nothing for others. The article calls for a broader view of dementia care that encompasses those who do not benefit from medication, emphasizing that their lives still require attention and respect. It argues for a shift in public discourse toward acknowledging the humanity of people living with advanced dementia and toward designing ethical engagement strategies that include them in research and creative activities where possible.

In sum, the piece advocates for a balanced approach to dementia: embrace the potential of disease-modifying therapies while sustaining a robust, humane care ecosystem that recognizes identity, supports connection, and avoids erasure of those in the most advanced stages of the condition. The author concludes with a call to maintain humility, relational care, and ethical imagination as dementia research and care continue to evolve.